ESC 365 - Doctor Seung-Jae Joo

Speaker illustration

Doctor Seung-Jae Joo

Jeju National University Hospital, Jeju (Korea (Republic of))

Member of:

Heart Failure Association

The clinical impact of improved or decreased left ventricular systolic function after the initial attack in patients with acute myocardial infarction

Event: Heart Failure 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Heart failure patient profile and outcome 1

Association of beta-blockers or inhibitors of renin-angiotensin system with clinical outcomes in patients with mid-range left ventricular ejection fraction after acute myocardial infarction

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters

Angiotensin receptor blockers, compared with angiotensin-converting enzyme inhibitors, increased recurrent myocardial infarction in hypertensive patients with acute myocardial infarction

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation

Association between six-month blood pressure level and 1-year heart failure in hypertensive patients with acute myocardial infarction

Event: Heart Failure 2018

Topic: Hypertension, Other

Session: Hypertension - Other

Beta-blockers in patients with preserved left ventricular systolic function after acute myocardial infarction did not improve clinical outcomes

Event: ESC Congress 2017

Topic: Adjunctive medical therapy

Session: Beta-blockers in acute coronary syndromes: the end of a dogma?

Anticoagulation in patients with acute myocardial infarction who were presenting with atrial fibrillation improved clinical outcomes

Event: ESC Congress 2016

Topic: Thrombosis and coagulation

Session: Thrombosis and antithrombotic in acute coronary syndrome

ESC 365 is supported by